Suspension of trading
Valuation Exscientia plc
Stocks
EXAI
US30223G1022
Biotechnology & Medical Research
|
Delayed
Nasdaq
00:00:00 20/11/2024 +03
|
5-day change | 1st Jan Change | ||
| 4.840 USD | +3.20% |
|
-.--% | - |
| 21/11/24 | Exscientia plc(NasdaqGS:EXAI) dropped from S&P Global BMI Index | CI |
| 20/11/24 | Recursion Pharmaceuticals, Exscientia Complete Business Combination | MT |
Company Valuation: Exscientia plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Market Cap 1 | 1,757 | 543.6 | 628.7 |
| Change | - | -69.06% | 15.67% |
| Enterprise Value (EV) 1 | 1,200 | 51.65 | 284.6 |
| Change | - | -95.69% | 451% |
| P/E | -14.8x | -4.55x | -4.28x |
| PBR | 3.11x | 1.14x | 1.78x |
| PEG | -0x | 3.03x | -0.2x |
| Capitalization / Revenue | 64.2x | 20x | 31.3x |
| EV / Revenue | 43.9x | 1.9x | 14.2x |
| EV / EBITDA | -23.4x | -0.32x | -1.75x |
| EV / EBIT | -22x | -0.31x | -1.63x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -0.9871 | -0.9722 | -1.175 |
| Distribution rate | - | - | - |
| Net sales 1 | 27.36 | 27.22 | 20.08 |
| EBITDA 1 | -51.31 | -159.9 | -162.5 |
| EBIT 1 | -54.64 | -167.6 | -174.5 |
| Net income 1 | -49.23 | -118.7 | -146 |
| Net Debt 1 | -557 | -491.9 | -344.1 |
| Reference price 2 | 14.593 | 4.424 | 5.032 |
| Nbr of stocks (in thousands) | 120,388 | 122,878 | 124,940 |
| Announcement Date | 3/23/22 A | 3/23/23 A | 3/21/24 A |
1GBP in Million2GBP
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 633M | ||
| 32.07x | 5.77x | 17.28x | 1.01% | 46.68B | ||
| 34.76x | 3.35x | 14.44x | -.--% | 44.42B | ||
| -19.81x | 213.44x | -21.53x | -.--% | 41.32B | ||
| 47.9x | 5.56x | 30.41x | -.--% | 41.58B | ||
| 27.45x | 7.91x | 20.36x | 0.41% | 30.14B | ||
| 35.5x | 5.83x | 26.48x | -.--% | 17.42B | ||
| 26.02x | 2.23x | 9.67x | 1.03% | 15.54B | ||
| -56.03x | 9.2x | 224.52x | -.--% | 14.08B | ||
| Average | 15.98x | 31.66x | 40.20x | 0.31% | 27.98B | |
| Weighted average by Cap. | 21.00x | 39.70x | 24.72x | 0.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EXAI Stock
- Valuation Exscientia plc
Select your edition
All financial news and data tailored to specific country editions
















